๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Hexamethylmelamine, adriamycin, and cyclophosphamide (HAC) versuscis-dichlorodiamineplatinum, adriamycin, and cyclophosphamide (PAC) in advanced ovarian cancer: A randomized clinical trial

โœ Scribed by Cristiana Sessa; Giorgio Bolis; Nicoletta Colombo; Maurizio D'Incalci; Bernadette Mermillod; Ivana Valente; Costantino Mangioni


Publisher
Springer
Year
1985
Tongue
English
Weight
659 KB
Volume
14
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Treatment of advanced ovarian cancer: A
โœ Bezwoda, W. R. ๐Ÿ“‚ Article ๐Ÿ“… 1986 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 395 KB

Fifty-one patients with ovarian cancer were tients with < 2 cm residual disease had sigentered in a randomised trial comparing treat-nificantly higher rate of complete remission rnent with cisplatin + adriamycin + cyclo-than those with > 2 crn residual disease. Carphosphamide (PAC) to cisplatin + 4'

A randomized multicenter trial of cyclop
โœ John M. Bennett; Patrick Byrne; Ajit Desai; Charles White; Ronald DeConti; Charl ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› Springer US ๐ŸŒ English โš– 388 KB

As of August 1984, 115 women with advanced breast cancer have been randomized to receive a combination of either cyclophosphamide, Novantrone (mitoxantrone) and 5-fluorouracil (CNF) or cyclophosphamide, Adriamycin (doxorubicin) and 5-fluorouracil (CAF). Seventy-one percent of all patients were post-